Published in Cancer on November 01, 2006
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. J Clin Oncol (2011) 7.65
Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Oncol (2010) 3.11
The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas (2010) 2.84
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid (2015) 2.67
Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer. Thyroid (2014) 2.25
Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits. Diabetes Care (2010) 1.91
Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer. J Clin Endocrinol Metab (2010) 1.59
Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist (2014) 1.43
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbecks Arch Surg (2013) 1.23
Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS. J Clin Endocrinol Metab (2012) 1.21
New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin (2013) 1.16
Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol (2012) 1.15
Medullary thyroid cancer: monitoring and therapy. Endocrinol Metab Clin North Am (2007) 1.14
Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab (2011) 1.11
RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer. Expert Rev Anticancer Ther (2008) 1.10
Update multiple endocrine neoplasia type 2. Fam Cancer (2010) 1.06
Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update. J Clin Endocrinol Metab (2013) 1.05
Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models. J Thyroid Res (2014) 1.02
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies. Adv Ther (2013) 0.96
The occurrence of rare cancers in U.S. adults, 1995-2004. Public Health Rep (2010) 0.96
Medullary carcinoma of the thyroid with axillary metastasis: a case report. Int Surg (2015) 0.96
Treatment of advanced medullary thyroid cancer. Thyroid Res (2013) 0.94
The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. J Clin Endocrinol Metab (2013) 0.91
Sporadic medullary thyroid carcinoma with a pedunculated intraluminal internal jugular vein recurrence: A case report and literature review. Int J Surg Case Rep (2011) 0.89
Epigenetics modifications and therapeutic prospects in human thyroid cancer. Front Endocrinol (Lausanne) (2012) 0.89
Role of vandetanib in the management of medullary thyroid cancer. Biologics (2012) 0.88
Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer. Cancer Med (2014) 0.87
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. Virchows Arch (2014) 0.85
Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat--and with which drug--those are the questions. J Clin Endocrinol Metab (2014) 0.83
Advanced medullary thyroid cancer: pathophysiology and management. Cancer Manag Res (2013) 0.83
Aurora kinases are expressed in medullary thyroid carcinoma (MTC) and their inhibition suppresses in vitro growth and tumorigenicity of the MTC derived cell line TT. BMC Cancer (2011) 0.83
Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction. Mol Cancer Ther (2014) 0.82
Update: the status of clinical trials with kinase inhibitors in thyroid cancer. J Clin Endocrinol Metab (2014) 0.82
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer. Clin Med Insights Oncol (2011) 0.82
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers. Curr Genomics (2011) 0.82
Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma. Int J Endocrinol (2013) 0.81
Autophagy: A potential target for thyroid cancer therapy (Review). Mol Clin Oncol (2014) 0.79
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging (2014) 0.79
Clinical utility of vandetanib in the treatment of patients with advanced medullary thyroid cancer. Onco Targets Ther (2011) 0.78
Overview and management of dermatologic events associated with targeted therapies for medullary thyroid cancer. Thyroid (2014) 0.78
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial. Eur J Pharm Sci (2016) 0.78
Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer. Ann Surg Oncol (2014) 0.77
Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases. Clinics (Sao Paulo) (2009) 0.77
Acute liver failure secondary to metastatic medullary thyroid cancer. Case Reports Hepatol (2012) 0.77
Molecular diagnosis and comprehensive treatment of multiple endocrine neoplasia type 2 in Southeastern Chinese. Hered Cancer Clin Pract (2015) 0.77
Noncoding RNAs in endocrine malignancy. Oncologist (2014) 0.76
Patterns of thyroid hormone levels in pediatric medullary thyroid carcinoma patients on vandetanib therapy. Int J Pediatr Endocrinol (2015) 0.76
Cabozantinib for progressive metastatic medullary thyroid cancer: a review. Ther Clin Risk Manag (2014) 0.75
Synchronous multifocal medullary and papillary thyroid microcarcinoma detected by elastography. Int J Surg Case Rep (2013) 0.75
Recurrent spinal metastasis of a sporadic medullary carcinoma of the thyroid after radiation therapy: a case report and review of the literature. Clin Case Rep (2015) 0.75
Hereditary medullary thyroid carcinoma: the management dilemma. Fam Cancer (2012) 0.75
Arriving at the Right Diagnosis in an Era of Precision Medicine. Case Rep Oncol (2016) 0.75
Ectopic ACTH Production Leading to Diagnosis of Underlying Medullary Thyroid Carcinoma. J Investig Med High Impact Case Rep (2016) 0.75
Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry. Gland Surg (2016) 0.75
Ultrasonographic characteristics of medullary thyroid carcinoma: a comparison with papillary thyroid carcinoma. Oncotarget (2017) 0.75
Routine calcitonin measurement in nodular thyroid disease management: is it worthwhile? Ann Surg Treat Res (2017) 0.75
Thyroid: Medullary Carcinoma. Atlas Genet Cytogenet Oncol Haematol (2013) 0.75
A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology. Thyroid (2016) 0.75
Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing's syndrome in a medullary thyroid carcinoma patient. Endocrinol Diabetes Metab Case Rep (2016) 0.75
Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004-2013). Eur Thyroid J (2016) 0.75
Selective use of vandetanib in the treatment of thyroid cancer. Drug Des Devel Ther (2015) 0.75
Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Oncology (2016) 0.75
A diagnostic dilemma: a young boy with loss of weight, pulmonary infiltrates and cervical lymphadenitis. J Clin Diagn Res (2013) 0.75
Medullary thyroid carcinoma: The third most common thyroid cancer reviewed. Oncol Lett (2010) 0.75
Clinical challenges with calcitonin-negative medullary thyroid carcinoma. J Cancer Res Clin Oncol (2016) 0.75
A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy. Thyroid Res (2017) 0.75
Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India. World J Surg (2011) 0.75
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid (2011) 7.17
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract (2011) 3.40
Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care (2002) 3.37
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet (2005) 2.85
Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. J Clin Endocrinol Metab (2012) 2.78
Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg (2014) 2.15
Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancer. J Clin Endocrinol Metab (2015) 2.14
Determinants of willingness to donate living related and cadaveric organs: identifying opportunities for intervention. Transplantation (2002) 2.06
Race as a predictor of morbidity, mortality, and neurologic events after carotid endarterectomy. J Vasc Surg (2013) 2.03
Attitudes, training experiences, and professional expectations of US general surgery residents: a national survey. JAMA (2009) 1.72
Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? Ann Surg Oncol (2010) 1.62
Impact of family and gender on career goals: results of a national survey of 4586 surgery residents. Arch Surg (2010) 1.59
"Join the club": effect of resident and attending social interactions on overall satisfaction among 4390 general surgery residents. Arch Surg (2012) 1.57
American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid (2012) 1.57
The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg (2011) 1.55
Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States. Ann Surg Oncol (2014) 1.53
Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther (2013) 1.52
Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw (2015) 1.51
Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1,408 cases. Surgery (2009) 1.28
Spontaneous adrenal hemorrhage with associated masses: etiology and management in 6 cases and a review of 133 reported cases. World J Surg (2012) 1.26
Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis. J Clin Endocrinol Metab (2008) 1.23
NHE3 regulatory complexes. J Exp Biol (2009) 1.19
Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? Arch Surg (2009) 1.17
Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol (2012) 1.15
Primary thyroid lymphoma: a review of recent developments in diagnosis and histology-driven treatment. Curr Opin Oncol (2010) 1.14
Sclerosing epithelioid fibrosarcoma of the cecum: a radiation-associated tumor in a previously unreported site. Arch Pathol Lab Med (2007) 1.14
Prevalence and association between obesity and metabolic syndrome among Chinese elementary school children: a school-based survey. BMC Public Health (2010) 1.14
Assessment and management of patients with abnormal calcium. Crit Care Med (2004) 1.10
Initial experience with a synthetic sealant PleuraSeal after pulmonary resections: a prospective study with retrospective case matched controls. J Cardiothorac Surg (2010) 1.10
NHERF1 and NHERF2 are necessary for multiple but usually separate aspects of basal and acute regulation of NHE3 activity. Am J Physiol Cell Physiol (2010) 1.09
Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg (2009) 1.08
The effects of Buyang Huanwu Decoction on hemorheological disorders and energy metabolism in rats with coronary heart disease. J Ethnopharmacol (2011) 1.07
Rehospitalization among elderly patients with thyroid cancer after thyroidectomy are prevalent and costly. Ann Surg Oncol (2010) 1.07
A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol (2013) 1.07
The general public's concerns about clinical risk in live kidney donation. Am J Transplant (2002) 1.05
Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid (2011) 1.03
Critical role for Kalirin in nerve growth factor signaling through TrkA. Mol Cell Biol (2005) 1.00
Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York State. Ann Surg Oncol (2010) 1.00
Medullary thyroid carcinoma without marked elevation of calcitonin: a diagnostic and surveillance dilemma. Thyroid (2008) 0.97
Malignant struma ovarii: a population-level analysis of a large series of 68 patients. Thyroid (2014) 0.96
Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope. Curr Opin Oncol (2008) 0.96
Medullary thyroid cancer: early detection and novel treatments. Curr Opin Oncol (2009) 0.96
Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery (2005) 0.95
Age matters: a study of clinical and economic outcomes following cholecystectomy in elderly Americans. Am J Surg (2011) 0.95
Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit. J Ethnopharmacol (2007) 0.94
NHE3 mobility in brush borders increases upon NHERF2-dependent stimulation by lyophosphatidic acid. J Cell Sci (2010) 0.94
Missing call bias in high-throughput genotyping. BMC Genomics (2009) 0.94
Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats. J Ethnopharmacol (2010) 0.93
Early clinical and economic outcomes of patients undergoing living donor nephrectomy in the United States. Arch Surg (2010) 0.93
Hypoxia activates heparanase expression in an NF-kappaB dependent manner. Oncol Rep (2010) 0.91
The roles of buyang huanwu decoction in anti-inflammation, antioxidation and regulation of lipid metabolism in rats with myocardial ischemia. Evid Based Complement Alternat Med (2011) 0.91
A common polymorphism is associated with body mass index in Uyghur population. Diabetes Res Clin Pract (2008) 0.91
SIRT1 inhibits TNF-α-induced apoptosis of vascular adventitial fibroblasts partly through the deacetylation of FoxO1. Apoptosis (2013) 0.91
Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl (2014) 0.91
To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy. Ann Surg Oncol (2010) 0.91
Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. Ann Surg Oncol (2014) 0.90
Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis (2006) 0.90
Valsartan attenuates oxidative stress and NF-κB activation and reduces myocardial apoptosis after ischemia and reperfusion. Eur J Pharmacol (2013) 0.90
Outdated and incomplete: a review of thyroid cancer on the World Wide Web. Thyroid (2007) 0.89
Down-regulation of CD40 gene expression and inhibition of apoptosis with Danshensu in endothelial cells. Basic Clin Pharmacol Toxicol (2008) 0.88
Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists. J Clin Gastroenterol (2008) 0.88
Primary leiomyosarcoma of the thyroid gland. Thyroid (2008) 0.88
Treatment patterns of aging Americans with differentiated thyroid cancer. Cancer (2010) 0.87
Tanshinone IIA inhibits atherosclerotic plaque formation by down-regulating MMP-2 and MMP-9 expression in rabbits fed a high-fat diet. Life Sci (2007) 0.87
To stimulate or withdraw? A cost-utility analysis of recombinant human thyrotropin versus thyroxine withdrawal for radioiodine ablation in patients with low-risk differentiated thyroid cancer in the United States. J Clin Endocrinol Metab (2010) 0.87
Protective effects of chinese traditional medicine buyang huanwu decoction on myocardial injury. Evid Based Complement Alternat Med (2011) 0.86
Decolorization of textile azo dye and Congo red by an isolated strain of the dissimilatory manganese-reducing bacterium Shewanella xiamenensis BC01. Appl Microbiol Biotechnol (2013) 0.86
SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway. Cytokine (2012) 0.86
SIRT1 regulates CD40 expression induced by TNF-α via NF-ĸB pathway in endothelial cells. Cell Physiol Biochem (2012) 0.85
A Case Report of Esophageal Bronchogenic Cyst and Review of the Literature With an Emphasis on Endoscopic Ultrasonography Appearance. Medicine (Baltimore) (2016) 0.85
Telementoring: a multi-institutional experience with the introduction of a novel surgical approach for adrenalectomy. Ann Surg Oncol (2013) 0.84
Current advances in the diagnosis and treatment of pancreatic endocrine tumors. Curr Opin Oncol (2005) 0.84
PPARα agonist fenofibrate attenuates TNF-α-induced CD40 expression in 3T3-L1 adipocytes via the SIRT1-dependent signaling pathway. Exp Cell Res (2013) 0.84
Outcomes following cholecystectomy in pregnant and nonpregnant women. Surgery (2009) 0.84
Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocr Pract (2004) 0.83
Protective effects of paeoniflorin against cobalt chloride-induced apoptosis of endothelial cells via HIF-1α pathway. Toxicol In Vitro (2012) 0.83
Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats. J Physiol Biochem (2015) 0.82
Do not roll the videotape: effects of the health insurance portability and accountability act and the law on trauma videotaping practices. Am J Surg (2006) 0.82
The molecular diagnosis and management of thyroid neoplasms. Curr Opin Oncol (2012) 0.82
Determination of paeoniflorin, calycosin-7-O-β-D-glucoside, ononin, calycosin and formononetin in rat plasma after oral administration of Buyang Huanwu decoction for their pharmacokinetic study by liquid chromatography-mass spectrometry. Biomed Chromatogr (2010) 0.82
Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer. Clin Med Insights Oncol (2011) 0.82
Functional paragangliomas presenting as primary liver tumors. South Med J (2007) 0.82
Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein. Neurobiol Dis (2004) 0.81
Psychiatric and cognitive aspects of primary hyperparathyroidism. Curr Opin Oncol (2007) 0.81
The management of thyroid nodules in patients with primary hyperparathyroidism. J Surg Res (2008) 0.81
Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children? J Clin Res Pediatr Endocrinol (2012) 0.81
Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer. Core Evid (2010) 0.81
ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg (2010) 0.81
The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells. Inflammation (2014) 0.80
Filling a void: thyroid cancer surgery information on the internet. World J Surg (2007) 0.79
Experimental pancreatitis results in increased blood-brain barrier permeability in rats: a potential role of MCP-1. J Dig Dis (2012) 0.79
Predictors of outcomes following pediatric thyroid and parathyroid surgery. Curr Opin Oncol (2009) 0.79
AKT and GSK-3 are necessary for direct ezrin binding to NHE3 as part of a C-terminal stimulatory complex: role of a novel Ser-rich NHE3 C-terminal motif in NHE3 activity and trafficking. J Biol Chem (2014) 0.79
Differentiation potential of bone marrow stromal cells to enteric neurons in vitro. Chin J Dig Dis (2006) 0.79
The impact of implementing The Bethesda System for reporting of thyroid FNA at an academic center. Diagn Cytopathol (2013) 0.79
Trends and outcomes of endovascular and open treatment for traumatic thoracic aortic injury. J Vasc Surg (2010) 0.78
Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases. Am J Surg (2013) 0.78